Relationship between BRAF V600E mutation and L-T4 dosage required for TSH inhibition treatment reaching the standard after operation in patients with thyroid papillary carcinoma

ZHANG Jie; REN Hongzhen; GUO Yanying

doi:10.3969/j.issn.1002-266X.2022.32.008

Home>Articles>Relationship between BRAF V600E mutation and L-T4 dosage required for TSH inhibition treatment reaching the standard after operation in patients with thyroid papillary carcinoma

DOI: 10.3969/j.issn.1002-266X.2022.32.008

Relationship between BRAF V600E mutation and L-T4 dosage required for TSH inhibition treatment reaching the standard after operation in patients with thyroid papillary carcinoma

ZHANG Jie

REN Hongzhen

GUO Yanying

Machine-generated Keywords：

Publication Date：2022-11-15

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 37-40 )

Shandong Medical Journal

ISTICPKU

ISSN：1002-266X

Year, Vol.(Issue)：2022,62(32)